Citadel Advisors’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $519K | Buy |
|
|||||
|
2024
Q4 | $293K | Buy |
|
|||||
|
2024
Q3 | $121K | Sell |
|
|||||
|
2024
Q2 | $532K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.47M | Buy |
|
|||||
|
2023
Q3 | $576K | Buy |
|
|||||
|
2023
Q2 | $425K | Sell |
|
|||||
|
2023
Q1 | $465K | Sell |
|
|||||
|
2022
Q4 | $669K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $2.43M | Buy |
|
|||||
|
2022
Q1 | $1.06M | Sell |
|
|||||
|
2021
Q4 | $2.59M | Buy |
|
|||||
|
2021
Q3 | $267K | Sell |
|
|||||
|
2021
Q2 | $1.55M | Buy |
|
|||||
|
2021
Q1 | $1.19M | Sell |
|
|||||
|
2020
Q4 | $1.81M | Sell |
|
|||||
|
2020
Q3 | $1.76M | Buy |
|
|||||
|
2020
Q2 | $491K | Sell |
|
|||||
|
2020
Q1 | $625K | Sell |
|
|||||
|
2019
Q4 | $1.41M | Buy |
|
|||||
|
2019
Q3 | $591K | Sell |
|
|||||
|
2019
Q2 | $915K | Sell |
|
|||||
|
2019
Q1 | $5.48M | Sell |
|
|||||
|
2018
Q4 | $5.17M | Buy |
|
|||||
|
2018
Q3 | $7.45M | Buy |
|
|||||
|
2018
Q2 | $3.29M | Buy |
|
|||||
|
2018
Q1 | $2.73M | Buy |
|
|||||
|
2017
Q4 | $1.65M | Buy |
|
|||||
|
2017
Q3 | $925K | Buy |
|
|||||
|
2017
Q2 | $401K | Buy |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $1.32M | Buy |
|
|||||
|
2016
Q1 | $374K | Sell |
|
|||||
|
2015
Q4 | $5.43M | Buy |
|
|||||
|
2015
Q3 | $3.76M | Buy |
|
|||||
|
2015
Q2 | $4.93M | Buy |
|
|||||
|
2015
Q1 | $3.63M | Buy |
|
|||||
|
2014
Q4 | $2.48M | Buy |
|
|||||
|
2014
Q3 | $1.77M | Buy |
|
|||||
|
2014
Q2 | $828K | Buy |
|